Cytotoxic T lymphocytes carrying a pattern recognition protein Tag7 can detect evasive, HLA-negative but Hsp70-exposing tumor cells, thereby ensuring FasL/Fas-mediated contact killing

Blood

Volumn 110, Issue 6, 2007, Pages 1997-2004

  Sashchenko, Lidia P ^a   Dukhanina, Elena A ^a,b   Shatalov, Yury V ^a   Yashin, Denis V ^a,c   Lukyanova, Tamara I ^a   Kabanova, Olga D ^a   Romanova, Elena A ^a   Khaidukov, Sergei V ^d   Galkin, Alexander V ^a   Gnuchev, Nikolai V ^a   Georgiev, Georgii P ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c UNIVERSITY OF OSLO   (Norway)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HEAT SHOCK PROTEIN 70; HLA ANTIGEN; PROTEIN TAG; PROTEIN TAG7; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

EID: 34548848517     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-12-064444     Document Type: Article

References (39)

1. Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol. 1998;10:581-587.
2. Bubenik J. MHC class I down-regulation: tumour escape from immune surveillance? Int J Oncol. 2004;25:487-491.
3. Kunzmann V, Wilhelm M. Anti-lymphoma effect of gammadelta T cells. Leuk Lymphoma. 2005;46:671-680.
4. Seliger B. Strategies of tumor immune evasion. BioDrugs. 2005;19:347-354.
5. Sashchenko LP, Dukhanina EA, Yashin DV, et al. Peptidoglycan recognition protein tag7 forms a cytotoxic complex with heat shock protein 70 in solution and in lymphocytes. J Biol Chem. 2004;279:2117-2124.
6. Dziarski R. Peptidoglycan recognition proteins (PGRPs). Mol Immunol. 2004;40:877-886.
7. Hoffmann JA. The immune response of Drosophila. Nature. 2003;426:33-38.
8. Larin SS, Georgiev GP, Kiselev SL. Gene transfer approaches in cancer immunotherapy. Gene Ther. 2004;11:18-25.
9. Larin SS, Korobko EV, Kustikova OS, et al. Immunotherapy with autologous tumor cells engineered to secrete Tag7/PGRP, an innate immunity recognition molecule. J Gene Med. 2004;6:798-808.
10. Hantschel M, Pfister K, Jordan A, et al. Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones. 2000;5:438-442.
11. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer. 1992;51:613-619.
12. Deng XL, Chen W, Cai MY, Wei DP. Expression of class I MHC molecule, HSP70 and TAP in human hepatocellular carcinoma. World J Gastroenterol. 2003;9:1853-1855.
13. Ponomarev ED, Tarasenko TN, Sapozhnikov AM. Splenic cytotoxic cells recognize surface HSP70 on culture-adapted EL-4 mouse lymphoma cells. Immunol Lett. 2000;74:133-139.
14. Dressel R, Grzeszik C, Kreiss M, et al. Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes. Cancer Res. 2003;63:8212-8220.
15. Dressel R, Elsner L, Quentin T, Walter L, Gunther E. Heat shock protein 70 is able to prevent heat shock-induced resistance of target cells to CTL. J Immunol. 2000;164:2362-2371.
16. Calderwood SK, Theriault JR, Gong J. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol. 2005;35:2518-2527.
17. Massa C, Guiducci C, Arioli I, Parenza M, Colombo MP, Melani C. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res. 2004;64:1502-1508.
18. Ueda G, Tamura Y, Hirai I, et al. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. Cancer Sci. 2004;95:248-253.
19. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science. 1997;278:117-120.
20. Multhoff G, Botzler C, Wiesnet M, Eissner G, Issels R. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones. 2001;6:337-344.
21. Multhoff G, Mizzen L, Winchester CC, et al. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol. 1999;27:1627-1636.
22. Sashchenko LP, Gnuchev NV, Lukjanova TI, et al. Time-dependent changes of LAK cell phenotypes correlate with the secretion of different cytotoxic proteins. Immunol Lett. 1993;37:153-157.
23. Watanabe Y, Shimamori Y, Ozaki M, Uchida M, Fujimoto Y. Purification of a membrane-bound neutral endopeptidase from rat kidney and its activation by polyamines. J Biochem (Tokyo). 1984;95:1725-1732.
24. Altin JG, Pagler EB. A one-step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules. Anal Biochem. 1995;224:382-389.
25. Lanier LL, Warner NL. Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Methods. 1981;47:25-30.
26. Sashchenko LP, Dukhanina EA, Luk'ianova TI, et al. Molecular mechanisms of cytolytic processes induced by human LAK cells. Mol Biol (Mosk). 2000;34:816-820.
27. Dukhanina EA, Romanova EA, Kiselev SL, Sashchenko LP. Protein p70 is an effector molecule for cytokine Tag 7. Dokl Biol Sci. 2000;371:224-225.
28. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest. 2003;112:1437-1443.
29. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338-344.
30. Hayakawa M, Jayadev S, Tsujimoto M, Hannun YA, Ito F. Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. Biochem Biophys Res Commun. 1996;220:681-686.
31. Kim KW, Kim BJ, Chung CW, et al. Caspase cleavage product lacking amino-terminus of Ikappa-Balpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis. J Cell Biochem. 2002;85:334-345.
32. Vanhaesebroeck B, Van Bladel S, Lenaerts A, et al. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res. 1991;51:2469-2477.
33. Algarra I, Garcia-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother. 2004;53:904-910.
34. Sigal LH. Basic science for the clinician 35: CD1, invariant NKT (iNKT) cells, and gammadelta T-cells. J Clin Rheumatol. 2005;11:336-339.
35. Falk CS, Noessner E, Weiss EH, Schendel DJ. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells. Cancer Res. 2002;62:480-487.
36. Cho JH, Fraser IP, Fukase K, et al. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood. 2005;106:2551-2558.
37. Liu C, Xu Z, Gupta D, Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem. 2001;276:34686-34694.
38. Lo D, Tynan W, Dickerson J, et al. Peptidoglycan recognition protein expression in mouse Peyer's Patch follicle associated epithelium suggests functional specialization. Cell Immunol. 2003;224:8-16.
39. Tydell CC, Yuan J, Tran P, Selsted ME. Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion, and binding properties. J Immunol. 2006;176:1154-1162.